Biotech | March 12, 2024
USFDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin cancer therapy
It is the first autotaxin inhibitor to be investigated in cancer patients
It is the first autotaxin inhibitor to be investigated in cancer patients
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The institution will be spread over an area of more than 8 acres
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Women emerge as the cornerstone of this monumental undertaking
These approvals mark significant progress for Venus Remedies in expanding its market presence
The investment will catalyse various components of the IndiaAI Mission
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Subscribe To Our Newsletter & Stay Updated
